 Home > Biochemistry News > Biotechnology News > Determination of early markers of diseases such as Alzheimer's disease

Determination of early markers of diseases such as Alzheimer's disease

 Last Update: 2021-11-15
 Source: Internet
 Author: User

Tags

gabapentin dementia

stages aging

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Science and Technology Daily, Beijing, October 31.

Research has determined the molecular mechanism that causes the accumulation of this toxic protein

In the preclinical model of VAD, pups showed signs of brain inflammation and memory loss within one month

It is often difficult to translate information obtained from preclinical models into the human body, but this study provides reasons for optimism

Aging is a normal physical aging phenomenon.

Dementia is an umbrella term that covers Alzheimer's disease, which accounts for 60% to 80% of cases.

The researchers said that these two diseases may not be the only diseases affected by high levels of cis P-tau

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.